1-3 of 3
splenomegaly
Close
Sort by
Journal Articles

High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapy

Lynn H. Lee, Christa Krupski, Jason Clark, Mark Wunderlich, Robert B. Lorsbach, Michael S. Grimley, Matthew Burwinkel, Adam Nelson, Ashish R. Kumar
Journal: Blood Advances
Blood Adv (2020) 4 (4): 717–727.
https://doi.org/10.1182/bloodadvances.2019032367
Published: 2020
Includes: Supplemental data
Journal Articles

Phf6-null hematopoietic stem cells have enhanced self-renewal capacity and oncogenic potentials

Yueh-Chwen Hsu, Tsung-Chih Chen, Chien-Chin Lin, Chang-Tsu Yuan, Chia-Lang Hsu, Hsin-An Hou, Chein-Jun Kao, Po-Han Chuang, Yu-Ren Chen, Wen-Chien Chou, Hwei-Fang Tien
Journal: Blood Advances
Blood Adv (2019) 3 (15): 2355–2367.
https://doi.org/10.1182/bloodadvances.2019000391
Published: 2019
Includes: Supplemental data
Journal Articles

Impact of somatic and germline mutations on the outcome of systemic mastocytosis

Clinical Trials & Observations
Javier I. Muñoz-González, María Jara-Acevedo, Iván Alvarez-Twose, Jason D. Merker, Cristina Teodosio, Yanli Hou, Ana Henriques, Krishna M. Roskin, Laura Sanchez-Muñoz, Albert G. Tsai, Carolina Caldas, Almudena Matito, J. Ignacio Sánchez-Gallego, Andrea Mayado, Noelia Dasilva-Freire, Jason R. Gotlib, Luis Escribano, Alberto Orfao, Andrés C. García-Montero
Journal: Blood Advances
Blood Adv (2018) 2 (21): 2814–2828.
https://doi.org/10.1182/bloodadvances.2018020628
Published: 2018
Includes: Supplemental data